-The Times of India NEW DELHI: Overriding objections raised by senior officials, rural development minister Nitin Gadkari has ordered far-reaching changes in the job guarantee scheme (MGNREGS) which has provided seasonal work to one in three rural households in the last eight years. Documents obtained under the Right to Information (RTI) Act by activists show file notings by a senior official in the ministry arguing that Gadkari's announcements run contrary to the...

-Tehelka Despite the serious toll it takes on women's health, female sterilisation remains the most prevalent form of contraception in India. While memories of the 21 months of Emergency in 1975-77, imposed by the then prime minister Indira Gandhi, survives even today in the minds of Indian men as the fear of forced sterilisation, the country's population control policies have shifted over the years since then to target the politically less...

-The Times of India A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws. Several health policy experts and activists have issued statements urging India not to give in to US...

-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...